| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 02/14/2008 | CA2659967A1 Quinazoline derivatives |
| 02/14/2008 | CA2659894A1 Heteroaryl compounds useful as inhibitors of e1 activating enzymes |
| 02/13/2008 | EP1886999A2 Bicyclic heteroaromatic compound |
| 02/13/2008 | EP1885702A2 Quinazolinones |
| 02/13/2008 | EP1885701A2 2-amino-quinaz0lin-5-ones as hsp90 inhibitors useful in treating proliferation diseases |
| 02/13/2008 | EP1747205A4 Pharmaceutical compositions |
| 02/13/2008 | EP1299390B1 Pyrimidine compounds and their use in the preparation of a triazolo -pyrimidine carba nucleoside |
| 02/13/2008 | CN101124199A 5-substituted-2-phenylamino-benzamide as MEK inhibitor |
| 02/13/2008 | CN101121698A Diarylmiazines derivatives, preparation method and use thereof |
| 02/12/2008 | US7329757 Chloroazinium compounds: 2-chloro-5-methyl-1-(3-trifluoromethyl-phenyl)-pyridinium chloride; intermediates for preparting iminoazine herbicides: N-cyclopropyl-5-methyl-1-(3-trifluoromethylphenyl)-2(1H)-pyridineimine |
| 02/12/2008 | US7329672 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 02/12/2008 | US7329671 N2,N4-bis(3-hydroxyphenyl)-5-fluoro-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 02/12/2008 | US7329669 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 02/12/2008 | US7329668 For therapy of inflammatory diseases, immune diseases, and cancer |
| 02/12/2008 | US7329667 A hexahydro-1,5,6,8-tetraaza-acenaphthylene or -1,3,4-triazaphenalene derivatives; treatment of depression and anxiety; inflammatory bowel disease; treatment of conditions mediated by corticotropin-releasing factor |
| 02/12/2008 | US7329665 Quinazolinone derivative |
| 02/12/2008 | US7329655 Drugs that inhibit phosphorylation kinases as an antigrowth or antiproliferation agent |
| 02/12/2008 | US7329652 Janus Kinase JAK2 and JAK3; 4-chloro-6-(3,5-dimethylpiperazin-1-yl)pyrimidine; chemotherapeutic, antiproliferative, antiinflammatory, immunomodulatory agent; allergies, asthma, autoimmune diseases, transplant rejection, rheumatoid arthritis, multiple sclerosis |
| 02/12/2008 | CA2280270C Acrylonitrile compounds, process for their production and pesticides containing them |
| 02/07/2008 | WO2008016973A1 2,4-diaminoquinazolines for spinal muscular atrophy |
| 02/07/2008 | WO2008016692A2 Chemical compounds |
| 02/07/2008 | WO2008015563A2 Salts of rosuvastatin and processes for their preparation |
| 02/07/2008 | WO2008015517A2 Ep2 agonists |
| 02/07/2008 | WO2008015250A1 Pyrimidine compounds for combating pathogenic fungi and cancer |
| 02/07/2008 | US20080033174 Method for the Production of 3-Phenyl (Thio) Uracils and Dithiouracils |
| 02/07/2008 | US20080033172 Mutagenic Heterocycles |
| 02/07/2008 | US20080033170 Novel compounds |
| 02/07/2008 | US20080033042 Urea-and urethane-substituted acylureas, process for their preparation and their use |
| 02/07/2008 | US20080032998 Pyrazolopyrimidines, a process for their preparation and their use as medicine |
| 02/07/2008 | US20080032997 (5S)-5-methyl-5-({[6-[2-(trifluoromethyl)pyrimidin-5-yl]-3,4-dihydroisoquinolin-2(1H)-yl]sulfonyl}methyl)imidazolidine-2,4-dione; asthma, rhinitis, chronic obstructive pulmonary diseases (COPD), arthritis (such as rheumatoid arthritis and osteoarthritis), atherosclerosis, cancer |
| 02/07/2008 | US20080032986 Benzyl amines, a process for their production and their use as anti-inflammatory agents |
| 02/07/2008 | US20080032985 4-Substituted Quinoline Derivatives, Method and Intermediates for Their Preparation and Pharmaceutical Compositions Containing Them |
| 02/07/2008 | US20080032982 2-{2-[3-(4-chlorophenyl)acryloyl]-4-methylphenoxy}-4-phenylbutanoic acid; Peroxisome Proliferator Activated Receptors (PPAR); diabetes, dyslipidemia and/or atherosclerosis |
| 02/07/2008 | US20080032974 Compounds and therapeutical use thereof |
| 02/07/2008 | US20080032973 2-Quinazolinone compounds and methods of use |
| 02/07/2008 | US20080032970 Amide Derivatives of 7-Amino-3-Phenyl-Dihydropyrimido[4,5-D]Pyrimidinones, Their Manufacture and Use as Pharmaceutical Agents |
| 02/07/2008 | US20080032969 Novel compounds |
| 02/07/2008 | US20080032967 1,4-Disubstituted Naphthalenes as Inhibitors of P38 Map Kinase |
| 02/07/2008 | US20080032963 Aminopyrimidines useful as kinase inhibitors |
| 02/07/2008 | CA2659376A1 2,4-diaminoquinazolines for spinal muscular atrophy |
| 02/07/2008 | CA2658911A1 Pyrimidine compounds for combating pathogenic fungi and cancer |
| 02/07/2008 | CA2658479A1 Novel hiv reverse transcriptase inhibitors |
| 02/06/2008 | EP1883632A1 Vanilloid receptor ligands and their use in treatments |
| 02/06/2008 | CN101119976A HIV inhibiting 2-(4-cyanophenylamino) pyrimidine oxide derivatives |
| 02/06/2008 | CN101119975A Preparation of rosuvastatin |
| 02/06/2008 | CN101119974A Amide derivatives as PPAR activators |
| 02/06/2008 | CN100366605C Compounds to treat alzheimer's disease |
| 02/05/2008 | US7326812 Arylsulfonamidobenzylic compounds |
| 02/05/2008 | US7326789 E.g., 2-(4-Chloro-phenylsufonylamino)-4,5-dimethoxy-N-(4-(thiomorpholine-4-sulfonyl)-phenyl)-benzamide; cardiovascular disorders; hypotensive agents; angina pectoris, cardiac insufficiency, thrombolytic agents; atherosclerosis; activating soluble guanylate cyclase to adjust a disturbed cyclic GMP balance |
| 02/05/2008 | US7326717 Pyrimidine n-oxide compounds for stimulating the growth of keratin fibers and/or reducing loss thereof |
| 02/05/2008 | US7326715 4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives |
| 02/05/2008 | US7326713 Such as aurora-2 kinase or c-kit kinase; anticancer agents; based on benzo(4,5)furo(3,2-d)pyrimidine, 9-thia-1,5,7-triazafluorene, or pyrimido(5,4-b)indole rings; e.g. 6,7-dimethoxy-4-(4-(benzodioxol-5-ylmethylaminothiocarbonyl)-piperazin-1-yl)-5H-Pyrimido(5,4-b)indole |
| 02/05/2008 | US7326712 Substituted tricyclic compounds as protein kinase inhibitors |
| 02/05/2008 | US7326705 2-amino or carbonylamino-4-carbocyclic imidazoles and thiazoles; antiischemic agents, hypotensive agents, antiarrhythmia agents; can be coadministered with other drugs |
| 02/05/2008 | CA2417635C Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 02/05/2008 | CA2402686C Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 02/05/2008 | CA2339272C Nitrogen-containing heterocyclic carboxamide derivatives or salts thereof and antiviral agents comprising the same |
| 02/05/2008 | CA2205406C Novel benzyl pyrimidines |
| 01/31/2008 | WO2008012326A1 2,4-substituted quinazolines as lipid kinase inhibitors |
| 01/31/2008 | WO2008012296A1 Labelling of fusion proteins with synthetic probes |
| 01/31/2008 | WO2008012105A1 Crystalline erlotinib |
| 01/31/2008 | WO2007098507A3 Compositions and methods for inhibition of the jak pathway |
| 01/31/2008 | US20080027084 antiinflammatory agent, anticarcinogenic agent; for treating inflammatory diseases, allergic, autoimmune, metabolic, cancer, cardiovascular diseases |
| 01/31/2008 | US20080027083 Modulators of chemokine receptor activity crystalline forms and process |
| 01/31/2008 | US20080027080 Cyclic derivatives as modulators of chemokine receptor activity |
| 01/31/2008 | US20080027077 Novel biaromatic compounds that modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 01/31/2008 | US20080027076 Pyrimidines With Tie2 (Tek) Activity |
| 01/31/2008 | US20080027070 2-amino--5-substituted pyrimidine inhibitors |
| 01/31/2008 | US20080027066 Arylpiperazinyl Compounds |
| 01/31/2008 | US20080027051 Novel Heteroaryl Substituted Benzoxazoles |
| 01/31/2008 | US20080027050 Heterocyclic Amide Compound and Use Thereof as an Mmp-13 Inhibitor(Amended Ex Officio) |
| 01/31/2008 | US20080027037 Cyclic compounds |
| 01/31/2008 | US20080027036 S1P receptor modulating compounds and use thereof |
| 01/31/2008 | CA2659307A1 Crystalline erlotinib |
| 01/31/2008 | CA2657200A1 2,4-substituted quinazolines as lipid kinase inhibitors |
| 01/30/2008 | EP1882688A1 Labelling of fusion proteins with synthetic probes |
| 01/30/2008 | EP1881965A1 2-amino-4-phenylquinazoline derivates and their use as hsp90 modulators |
| 01/30/2008 | CN101115746A Novell processes for the preparation of a benzofuran |
| 01/30/2008 | CN101115725A 2' and 3' - substituted cyclobutyl nucleoside analogs for the treatment of viral infections and abnormal cellular proliferation |
| 01/30/2008 | CN101115717A Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists |
| 01/30/2008 | CN101115482A 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors |
| 01/30/2008 | CN100364994C Crystal form of Peimeiqusai disodium and its preparation |
| 01/30/2008 | CN100364993C Peimequizane salt and its preparation |
| 01/29/2008 | US7323472 Antiarthritic agents; sepsis shock; malaria; antiischemic agents; respiratory system disorders; brain disorders; congestive heart failure |
| 01/29/2008 | US7323465 Alkansulfonamides as endothelin antagonists |
| 01/29/2008 | CA2312885C 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof |
| 01/29/2008 | CA2311423C Method for treating hyperlipidemia |
| 01/29/2008 | CA2297417C Derivatives of acyl-piperazinyl-pyrimidines, their preparation and application as medicaments |
| 01/29/2008 | CA2255620C Novel anandamide amidase inhibitors as analgesic agents |
| 01/29/2008 | CA2220999C Process for the hydrogenation of imines |
| 01/24/2008 | WO2008011032A1 Quinazoline and pyridopyrimidine derivatives as p38 kinase inhibitors |
| 01/24/2008 | WO2008009963A2 Pyrimidine derivatives as modulators of parathyroid hormone receptors |
| 01/24/2008 | WO2008009691A1 Pyrimidine derivatives and their use as pesticides |
| 01/24/2008 | WO2008009458A1 2, 4 -di (arylaminio) -pyrimidine-5-carboxamide compounds as jak kinases inhibitors |
| 01/24/2008 | WO2008009209A1 Dihydropyrimidine compounds and their uses in preparation of medicaments for treating and preventing antiviral diseases |
| 01/24/2008 | WO2008009078A2 4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections |
| 01/24/2008 | WO2008009077A2 4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections |
| 01/24/2008 | WO2007126957A3 New compounds |
| 01/24/2008 | US20080021201 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 01/24/2008 | US20080021182 Cocatalyst-reacted bridged imine complexes of silicon or germanium, e.g., N,N'-bis(3,5-di-tert-butylsalicylidene)-1,2-diaminocyclohexanesilicon(IV) dichloride and N,N'-bis(3,5-di-tert-butylsalicylidene)-1,2-diaminocyclohexanegermanium(IV) dichloride; preparing isotactic polyolefins |